Takeda Pharmaceuticals buys San Diego biotech for $330M to enhance drug pipeline for celiac disease
SAN DIEGO - San Diego's PvP Biologics has been acquired by Takeda Pharmaceutical Co. Ltd. for up to $330 million after completing an early human trial on a treatment for celiac dis…
